Keeping Up a Dour Countenance on the Verge of a Big Market

Don’t let the public pronouncements of pain for pharma from healthcare reform confuse you. Big pharma has had the expansion of health insurance and finding deep pockets to cover the uninsured as its major goal for years. Pharma execs and policy people are trying to sound worried; it is hard.

More from Market Access

More from Pink Sheet